Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
---|
08/05/2010 | US20100197562 Functionally selective alpha2c adrenoreceptor agonists |
08/05/2010 | US20100196514 Calcium silicate-based composite cement and methods for the preparation |
08/05/2010 | US20100196497 Method of Treating Tissue Using Platelet-Rich Plasma in Combination with Low-Level Laser Therapy |
08/05/2010 | US20100196496 Compositions comprising polyunsaturated fatty acid monoglycerides or derivatives thereof and uses thereof |
08/05/2010 | US20100196489 Bone growth particles and osteoinductive composition thereof |
08/05/2010 | US20100196459 Therapeutic formulations containing venom or venom anti-serum either alone or in combination for the therapeutic prophylaxis and therapy of neoplasms |
08/05/2010 | US20100196427 Delayed-release glucocorticoid treatment of rheumatoid arthritis by improving signs and symptoms, showing major or complete clinical response and by preventing from joint damage |
08/05/2010 | US20100196406 Agents for the treatment of inflammatory diseases and methods of using same |
08/05/2010 | US20100196404 Methods of use of the taci/taci-l interaction |
08/05/2010 | US20100196399 LDL Receptor-Related Proteins 1 and 2 and Treatment of Bone or Cartilage Conditions |
08/05/2010 | US20100196333 Device and Process for Producing Fiber Products and Fiber Products Produced Thereby |
08/05/2010 | US20100196331 Compositions including anthocyanin or anthocyanidin for the prevention or treatment of articular cartilage-associated conditions |
08/05/2010 | US20100196322 Polymer for tissue engineering applications and drug delivery |
08/05/2010 | US20100196281 Use of resiniferatoxin (rtx) for producing an agent for treating joint pains and method for applying said agent |
08/05/2010 | CA2751041A1 Prophylactic agent or therapeutic agent for disease resulting from abnormal bone metabolism |
08/04/2010 | EP2214018A2 Methods, agents, and compound screening assays for inducing differentiation of undifferentiated mammalian cells into osteoblasts |
08/04/2010 | EP2213743A1 Albumin fusion proteins |
08/04/2010 | EP2213302A2 DR4 antibodies and uses thereof |
08/04/2010 | EP2212344A2 Use of slit, nephrin, ephrin or semaphorin for treatment of cartilage diseases |
08/04/2010 | EP2212323A2 Imidazo [1,2-a] pyridine derivatives useful as alk inhibitors |
08/04/2010 | EP2212300A1 4-benz0yl-1-substituted-piperazin-2-0ne derivatives as p2x7 modulators |
08/04/2010 | EP2212292A1 Amides useful as inhibitors of voltage-gated sodium channels |
08/04/2010 | EP2212290A1 Aryl amides useful as inhibitors of voltage-gated sodium channels |
08/04/2010 | EP2211878A2 Calcium-mediated effects of coral and methods of use thereof |
08/04/2010 | EP2211862A2 Csf-1r inhibitors for treatment of cancer and bone diseases |
08/04/2010 | EP1343769B1 Benzoylpyridazines |
08/04/2010 | CN201537256U Chinese medicinal patch for treating hyperosteogeny |
08/04/2010 | CN201536901U Neck pillow capable of placing auxiliary object |
08/04/2010 | CN1934122B Fused heterocycle derivative, medicinal composition containing the same, and medicinal use thereof |
08/04/2010 | CN101796072A Amino acid sequences directed against RANK-l and polypeptides comprising the same for the treatment of bone diseases and disorders |
08/04/2010 | CN101795698A Composition for prevention or treatment of disease associated with the production of autoantibody |
08/04/2010 | CN101795685A hydroxyproline compositions and uses thereof |
08/04/2010 | CN101792436A Benzimidazole derivatives used in the treatment of diseases associated with vanilloid receptor 1 |
08/04/2010 | CN101791383A Compound chicory series product and effect of adjusting blood sugar, blood fat and blood uric acid |
08/04/2010 | CN101791367A Traditional Chinese medicine plaster for activating blood circulation and relieving pain |
08/04/2010 | CN101791366A Method for testing quality of Discorea nipponica Makino in different places and medicinal materials of same genera |
08/04/2010 | CN101791357A Externally-applied ointment for treatment of lumbar disc herniation and preparation method thereof |
08/04/2010 | CN101791344A Traditional Chinese medicine and preparation method thereof |
08/04/2010 | CN101791341A Application of traditional Chinese medicine composition in preparing drug for treatment of osteoporosis |
08/04/2010 | CN101791318A Novel application of bacterial lipopolysaccharides |
08/04/2010 | CN101791317A Compound preparation for treating knee osteoarthritis |
08/04/2010 | CN101791288A Stable lenalidomide oral solid preparation |
08/04/2010 | CN101791150A Production method of silica gel sheet containing traditional Chinese medicines and being used for the health underpants |
08/04/2010 | CN101249187B Chinese medicine for curing neck protrusion of lumbar vertebral disc |
08/04/2010 | CN101081296B Method for preparing b type haemophilus influenzae capsular polysaccharide and united vaccines thereof |
08/04/2010 | CN101057959B Medicinal composition for treating derangement syndrome of small joints in lumbar spine and waist support |
08/03/2010 | US7767685 8-pyrazolo-xanthine derivatives such as 2-[3-(2,6-Dioxo-1,3-dipropyl-2,3,6,7-tetrahydro-1H-purin-8-yl)-5-methyl-pyrazol-1-yl]-N-phenyl-acetamide, used for treating asthma, rhinitis, dermatitis, diabetes, tumors, reperfusion injuries, inflammatory bowel disease, autoimmune diseases and vison defects |
08/03/2010 | US7767679 Sulfonylamino-derivatives as novel inhibitors of histone deacetylase |
08/03/2010 | US7767665 1,3-benzothiazinone derivatives and use thereof |
08/03/2010 | US7767207 Interleukin-18 specific immunoglobulins for treatment and prevention of autoimmune, respiratory, reproductive, heart, connective tissue, liver, bone and arthritic disorders |
08/03/2010 | CA2512926C Methods and compositions for inhibition of angiogenesis |
08/03/2010 | CA2441792C Carboline derivatives as inhibitors of phosphodiesterase 5 (pdes) for the treatment of cardiovascular diseases and erectile dysfunction |
08/03/2010 | CA2409828C Formulation based in heparin, glycosaminoglycan or heparinoid, use of the formulation and the formulation base |
08/03/2010 | CA2402199C Amidino compounds useful as nitric oxide synthase inhibitors |
08/03/2010 | CA2359776C Methods for the prevention and treatment of diseases caused by an inflammatory response mediated by endogenous substance p by using anti-substance p antibodies |
08/03/2010 | CA2306343C Novel aryloxy-alkyl-dialkylamines |
08/03/2010 | CA2294101C A combined pharmaceutical preparation comprising parathyroid hormone and a bone resorption inhibitor |
07/29/2010 | WO2010085158A1 Improved animal treatment |
07/29/2010 | WO2010084999A1 Immunosuppressive agents and prophylactic and therapeutic agents for autoimmune diseases |
07/29/2010 | WO2010084851A1 Peptide capable of binding to immunoglobulin |
07/29/2010 | WO2010084767A1 N-substituted saturated heterocyclic sulfone compounds with cb2 receptor agonistic activity |
07/29/2010 | WO2010084661A1 Composition, food, food material, pharmaceutical preparation, cosmetic and commodity each containing isothiocyanate compound |
07/29/2010 | WO2010084500A1 New combination of active ingredients containing a non steroidal anti inflammatory drug and a colchicoside derivative |
07/29/2010 | WO2010083752A1 High-purity febuxostat and the method for preparation |
07/29/2010 | WO2010083581A1 Method for preparing an immunostimulant from a brucella lysate, and product |
07/29/2010 | WO2010083573A1 The treatment or prophylaxis of organ and tissue fibrosis via modulation of cell division autoantigen (cda1) |
07/29/2010 | WO2010064012A3 Treatment of autoimmune disease by modulating annexin-i (lipocortin 1 ) |
07/29/2010 | WO2010056877A3 Haloalkyl containing compounds as cysteine protease inhibitors |
07/29/2010 | WO2010054321A3 Methods of treating autoimmune disorders and/or inflammatory disorders |
07/29/2010 | WO2010039920A3 Boldine compounds for promoting bone growth |
07/29/2010 | US20100190838 Connective Tissue Growth Factor Fragments and Methods and Uses Thereof |
07/29/2010 | US20100190813 Spiro [piperidine-4- 4' -thieno [3,2-c] pyran] derivatives and related compounds as inhibitors of the sigma receptor for the treatment of psychosis |
07/29/2010 | US20100190811 Pyrimidine derivatives and compositions as c-kit and pdgfr kinase inhibitors |
07/29/2010 | US20100190808 Tricyclic Compounds As Modulators of TNF-alpha Synthesis |
07/29/2010 | US20100190805 Preparation for the treatment of equine laminitis |
07/29/2010 | US20100190799 Phenazine compounds and use thereof in autoimmune and inflammatory diseases |
07/29/2010 | US20100190798 Pharmaceutical composition comprising racemic aminopterin |
07/29/2010 | US20100190790 Sigma receptor inhibitors |
07/29/2010 | US20100190788 Amide derivatives as kinase inhitors |
07/29/2010 | US20100190786 Indolin-2-ones and aza-indolin-2-ones |
07/29/2010 | US20100190776 Thiazoline and Oxazoline Derivatives and Their Methods of Use |
07/29/2010 | US20100190773 Anti-Cytokine Heterocyclic Compounds |
07/29/2010 | US20100190755 Tetracycline compounds for the treatment of rheumatoid arthritis and related methods of treatment |
07/29/2010 | US20100190750 GPR119 Receptor Agonists in Methods of Increasing Bone Mass and of Treating Osteoporosis and Other Conditions Characterized by Low Bone Mass, and Combination Therapy Relating Thereto |
07/29/2010 | US20100190696 Treatment of t-cell mediated diseases |
07/29/2010 | US20100189819 Neuro-degenerative inhibitor, neuro-endocrine modulator, and neuro-cerebral metabolism enhancer |
07/29/2010 | US20100189773 5-cyano-4- (pyrrolo [2,3] pyridine-3-yl) -pyrimidine derivatives useful as protein kinase inhibitors |
07/29/2010 | US20100189770 Bioerodible patch |
07/29/2010 | US20100189720 Novel card proteins involved in cell death regulation |
07/29/2010 | US20100189714 Polypeptides with enhanced anti-inflammatory and decreased cytotoxic properties and relating methods |
07/29/2010 | US20100189686 Albumin Fusion Proteins |
07/29/2010 | DE10392697B4 Extrakt von Peptid-verknüpften Glucanen und Peptid-verknüpfte Clucane mit nachweisbarer oraler Resorbierbarkeit aus Coriolus Versicolor und deren Reinigungsverfahren und Verwendungen Extract of peptide-linked glucans and peptide-linked Clucane with detectable oral absorbability from Coriolus versicolor and their cleaning methods and uses |
07/29/2010 | CA2750457A1 New combination of active ingredients containing a non steroidal anti inflammatory drug and a colchicoside derivative |
07/29/2010 | CA2747801A1 N-substituted saturated heterocyclic sulfone compounds with cb2 receptor agonistic activity |
07/28/2010 | EP2210956A2 Method to inhibit cell growth using oligonucleotides |
07/28/2010 | EP2210604A1 Pharmaceutical compositions combining a nonsteroidal anti-inflammatory agent and a xanthine oxidase inhibiting agent, which can be used to control and treat gout, gouty arthritis and related diseases |
07/28/2010 | EP2210507A1 Bone-strengthening food material |
07/28/2010 | EP2210092A2 Compositions comprising semaphorins for the treatment of angiogenesis related diseases and methods of selection thereof |
07/28/2010 | EP2209805A1 An antigen associated with rheumatoid arthritis |
07/28/2010 | EP2209771A1 Cyclobutyl carboxylic acid derivatives |